➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Express Scripts
McKesson
Baxter
Harvard Business School
Merck

Last Updated: August 1, 2021

DrugPatentWatch Database Preview

BENZONATATE Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

Which patents cover Benzonatate, and when can generic versions of Benzonatate launch?

Benzonatate is a drug marketed by Alembic Labs, Apotex Inc, Ascent Pharms Inc, Bionpharma Inc, Cspc-nbp Pharm, Mikart, Nesher Pharms, Puracap Pharm Llc, Qingdao Baheal Pharm, Strides Pharma, Sun Pharm Inds Inc, Thepharmanetwork Llc, and Zydus Pharms Usa. and is included in fifteen NDAs.

The generic ingredient in BENZONATATE is benzonatate. There are six drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the benzonatate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Benzonatate

A generic version of BENZONATATE was approved as benzonatate by BIONPHARMA INC on January 29th, 1993.

  Try it Free

Drug patent expirations by year for BENZONATATE
Drug Prices for BENZONATATE

See drug prices for BENZONATATE

Drug Sales Revenue Trends for BENZONATATE

See drug sales revenues for BENZONATATE

Recent Clinical Trials for BENZONATATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Phase 1
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Phase 3
PfizerPhase 1

See all BENZONATATE clinical trials

Pharmacology for BENZONATATE

US Patents and Regulatory Information for BENZONATATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Thepharmanetwork Llc BENZONATATE benzonatate CAPSULE;ORAL 040749-001 Jul 25, 2007 AA RX No Yes ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Zydus Pharms Usa BENZONATATE benzonatate CAPSULE;ORAL 040597-001 Jun 8, 2007 AA RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Alembic Labs BENZONATATE benzonatate CAPSULE;ORAL 040682-001 Jul 30, 2007 AA RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Puracap Pharm Llc BENZONATATE benzonatate CAPSULE;ORAL 206948-002 Dec 19, 2018 AA RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Sun Pharm Inds Inc BENZONATATE benzonatate CAPSULE;ORAL 040587-001 Mar 19, 2008 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Express Scripts
McKesson
Baxter
Harvard Business School
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.